DR REDDYS LABORATORIES LTD — Board/Management Information 2025

Jul 24, 2025

Dr. Reddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India

CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com

July 24, 2025

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY) BSE Limited. (Scrip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") and in furtherance to our intimation dated May 09, 2025, wherein we had informed you that the Board of Directors of the Company at their meeting held on the same day, based on the recommendation of Nomination, Governance and Compensation Committee, have approved the re-appointment of Mr. G V Prasad (DIN: 00057433) as a Whole-Time Director designated as Co-Chairman and Managing Director for a period of 5 years with effect from January 30, 2026 to January 29, 2031, subject to approval of shareholders in the ensuing Annual General Meeting of the Company.

This is to inform you that the shareholders of the Company at their 41st AGM held today i.e. July 24, 2025 have approved the re-appointment of Mr. G V Prasad (DIN: 00057433) as a Whole-Time Director designated as Co-Chairman and Managing Director with requisite majority.

The details required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is enclosed as Annexure-I.

This is for your information and records.

Thanking you.

Yours faithfully, For Dr. Reddy's Laboratories Limited K Randhir Singh Company Secretary, Compliance Officer & Head-CSR KUMAR RANDHIR SINGH Digitally signed by KUMAR RANDHIR SINGH Date: 2025.07.24 21:19:56 +05'30'

Encl: as above

Annexure-I

Details under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

Sl.no.	Particulars	Details
1.	Reason for change viz.appointment, reappointment,resignation, removal, death orotherwise	Re-appointment of Mr. G V Prasad (DIN: 00057433) as aWhole-TimeDirectordesignatedasCo-ChairmanandManaging Director for a period of 5 years with effect fromJanuary 30, 2026 to January 29, 2031.
2.	Date of appointment / reappointment / cessation (asapplicable) & term ofappointment / re-appointment	Date of re-appointment–Effective from January 30, 2026Term-5 years commencing from January 30, 2026 to January29, 2031.
3.	Brief profile (in case ofappointment)	Mr. G V Prasad is one of our promoters and a member of ourBoard of Directors. He serves as our Co-Chairman andManaging Director. He has a Bachelor of Engineering degree inChemical Engineering from Illinois Institute of Technology,Chicago in the United States of America, and an M.S. inIndustrial Administration from Purdue University, Indiana inUnited States of America. Mr. Prasad's emphasis on research,innovation, transparency, business ethics and leaner corporatestructures has helped shape Dr. Reddy's into what it is today -an organization of global repute, recognized industry-wide forscientific innovation, progressive people practices and highstandards of corporate governance. He is driving the necessaryimperatives for our company to engage evenmore deeply withthe human aspects of health. Mr. Prasad focuses on mentoringleaders,drivinginnovationinscience,technologyanddigitalization while championing the cause of the planet,purpose, and patients. Mr. Prasad also ensures that the companyis well-positioned for our future, drawing upon his 36 years plusof leadership experience in the pharmaceutical industry to helpour company anticipate trends and envision the future ofhealthcare.
		Mr. Prasad is active on the boards of public and privateinstitutions such as the Indian School of Business (ISB) and theInternational Foundation for Research and Education. Mr.Prasad is also a member of the governing body of MckinseyCentre for CEO Excellence and Institute of Public HealthSciences Hyderabad Society. Mr. Prasad was listed among theTop 50 CEOs that India ever had by Outlook magazine in 2017and was recognized as one the top 5 Most Valuable CEOs ofIndia by Business World in 2016. He was also listed in the

		prestigious 'Medicine Maker 2018 Power List' of mostinspirationalprofessionalsshapingthefutureofdrugdevelopment, and has been named India Business Leader of theyear by CNBC Asia, in 2014 & 2015.
4.	Disclosure of relationshipsbetween directors (in case ofappointment of a director)	Mr. G V Prasad is brother-in-law of Mr. K Satish Reddy,Chairman of the Company.
5.	Information as required underBSE circular no.LIST/COMP/14/2018-19 andNSE circular no.NSE/CML/2018/24, datedJune 20, 2018	Mr. G V Prasad is not debarred from holding the office ofdirector by virtue of any SEBI order or any other suchauthority.